Vera Therapeutics Inc Class A (VERA)
R&D Expense Growth
-30.15%
Quarterly · Period ending:
VERA R&D Expense Growth
Latest reported-30.15%period ending
Latest reported-30.15%period ending
VERA Quarterly R&D Growth (QoQ) (0.00% → -30.15%)
Latest values, visible window
High-resolution chart · PNG
VERA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -30.1485% | |
| 45.0194% | |
| 5.0236% | |
| -2.959% | |
| 40.9831% | |
| 23.7832% | |
| -17.2818% | |
| 37.5388% | |
| 18.8171% | |
| 12.377% | |
| 36.3478% | |
| -0.8071% | |
| -36.6323% | |
| -3.9811% | |
| 35.7143% | |
| 94.3829% | |
| -19.4199% | |
| -1.5996% | |
| 257.8283% | |
| 10.17% | |
| 10.3342% | |
| -92.6413% | |
| 1,923.5653% | |
| 0.7677% | |
| 35.7887% | |
| 0% |